DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $71,000 | -14.5% | 17,640 | +4.2% | 0.00% | -33.3% |
| Q3 2019 | $83,000 | -19.4% | 16,930 | 0.0% | 0.00% | -57.1% |
| Q2 2019 | $103,000 | +7.3% | 16,930 | +2.8% | 0.01% | +16.7% |
| Q1 2019 | $96,000 | -55.8% | 16,470 | +2.2% | 0.01% | -53.8% |
| Q4 2018 | $217,000 | -37.5% | 16,120 | +18.7% | 0.01% | -27.8% |
| Q2 2018 | $347,000 | -10.3% | 13,580 | -29.4% | 0.02% | -5.3% |
| Q1 2018 | $387,000 | +7.2% | 19,230 | +6.9% | 0.02% | +5.6% |
| Q4 2017 | $361,000 | -3.2% | 17,990 | 0.0% | 0.02% | -10.0% |
| Q3 2017 | $373,000 | +145.4% | 17,990 | +75.5% | 0.02% | +150.0% |
| Q2 2017 | $152,000 | -2.6% | 10,250 | +4.9% | 0.01% | +14.3% |
| Q1 2017 | $156,000 | +25.8% | 9,770 | -1.1% | 0.01% | +16.7% |
| Q4 2016 | $124,000 | -44.9% | 9,880 | +22.7% | 0.01% | -50.0% |
| Q3 2016 | $225,000 | -18.5% | 8,050 | +2.0% | 0.01% | -20.0% |
| Q2 2016 | $276,000 | – | 7,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |